Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.35 USD | +3.48% | -4.63% | +13.83% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.83% | 28.07M | |
+0.82% | 43.84B | |
+6.07% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+5.98% | 25.53B | |
-24.37% | 18.18B | |
-3.40% | 12.29B | |
+26.15% | 12.29B | |
+6.90% | 11.15B |
- Stock Market
- Equities
- APRE Stock
- News Aprea Therapeutics, Inc.
- Aprea Therapeutics : Granted FDA Orphan Drug Designation for Eprenetapopt to Treat Leukemia; Shares Rise Midday